• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[结直肠癌患者的肿瘤标志物癌胚抗原(CEA)和糖类抗原19.9(CA-19.9)]

[The tumor markers CEA and CA-19.9 in patients with colorectal carcinoma].

作者信息

Ralchev K, Dudunkov Z, Dimitrov V, Stancheva Iu, Tsingilev D

出版信息

Khirurgiia (Sofiia). 1991;44(1):53-7.

PMID:1942906
Abstract

The levels of two tumor markers--CEA and CA-19.9 were repeatedly determined in 146 patients with histologically verified colo-rectal cancer and in 58 healthy controls. The normal CA-19.9 values were up to 30 U/ml. The sensitivity of the two markers proved to be low: 48.8 per cent for CEA and 37 per cent for CA-19.9. In 26 of 35 patients with local recurrence or metastases marker increase preceded the appearance of clinical symptoms of progression of the pathologic process. The two markers appeared more informative than each of them when separately determined.

摘要

对146例经组织学证实的结直肠癌患者和58例健康对照者反复测定了两种肿瘤标志物——癌胚抗原(CEA)和糖类抗原19-9(CA-19.9)的水平。CA-19.9的正常数值上限为30 U/ml。结果证明这两种标志物的敏感性较低:CEA为48.8%,CA-19.9为37%。在35例出现局部复发或转移的患者中,有26例在病理过程进展的临床症状出现之前标志物就升高了。这两种标志物联合检测时比单独检测更具信息量。

相似文献

1
[The tumor markers CEA and CA-19.9 in patients with colorectal carcinoma].[结直肠癌患者的肿瘤标志物癌胚抗原(CEA)和糖类抗原19.9(CA-19.9)]
Khirurgiia (Sofiia). 1991;44(1):53-7.
2
[The pre- and postoperative monitoring of the immunological indices and tumor markers in colorectal carcinoma].[结直肠癌免疫指标及肿瘤标志物的术前和术后监测]
Khirurgiia (Sofiia). 1998;51(3):42-8.
3
[The value of tumor markers in colorectal cancer].[肿瘤标志物在结直肠癌中的价值]
Leber Magen Darm. 1989 Jan;19(1):18-25.
4
[Is follow-up of breast cancer with CEA and CA 15-3 justified?].[癌胚抗原(CEA)和糖类抗原15-3(CA 15-3)用于乳腺癌随访是否合理?]
Helv Chir Acta. 1992 May;59(1):225-9.
5
[Significance of CEA and CA 19-9 for after care of curatively resected colorectal cancers].[癌胚抗原(CEA)和糖类抗原19-9(CA 19-9)对根治性切除结直肠癌术后随访的意义]
Zentralbl Chir. 1992;117(2):77-80.
6
Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer.结直肠癌中癌胚抗原、糖类抗原19-9、唾液酸化Tn抗原和涎液化糖链抗原X的血清学研究
Hepatogastroenterology. 1999 Mar-Apr;46(26):914-9.
7
CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.癌胚抗原(CEA)、组织多肽特异性抗原(TPS)、糖类抗原19-9(CA 19-9)、糖类抗原72-4(CA 72-4)及粪便潜血试验在结直肠癌手术切除术前诊断及随访中的应用
Anticancer Res. 1999 Jul-Aug;19(4A):2443-50.
8
Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer.血清肿瘤标志物癌胚抗原(CEA)、糖类抗原50(CA 50)和糖类抗原242(CA 242)在结直肠癌中的临床评估
Anticancer Res. 1994 May-Jun;14(3B):1427-32.
9
Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.癌胚抗原(CEA)、组织多肽抗原(TPA)、金标免疫渗滤法(GICA)、糖类抗原72.4(CA 72.4)及糖类抗原195(CA 195)在原发性结直肠癌诊断及其复发诊断中的应用价值
Cancer Detect Prev. 1995;19(2):183-95.
10
Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen.
Cancer Res. 1993 Apr 15;53(8):1788-93.